Azithromycin EP Impurity A is a structurally related byproduct arising from the glycosylation pathway during azithromycin synthesis. It features a 14-membered lactone core with a truncated desosamine sugar moiety, lacking the 3'-acetyl group present in the parent compound. This impurity exhibits a hydroxyl substitution at the C-9 position of the macrolide ring, distinguishing it from azithromycinβs methylated analog. It serves as a critical HPLC reference standard for quantifying process-related impurities in azithromycin drug substances.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1045600 β | 100 mg | USD 930.00 |
CC[C@@H]1[C@@]([C@@H]([C@H](NC[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)38-18-19(2)16-35(8,44)32(51-34-28(40)25(39(11)12)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
HRKNNHYKWGYTEN-HOQMJRDDSA-N